$ENSC Cashflow Statement | Understand Stock

$ENSC

$0.45 -$0.02 (4.36%) Close

$ENSC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statement of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Gain on sale of asset
Accrued interest
Accretion of discounts on promissory notes
Change in fair value of convertible debt
Change in fair value of derivative liability
Change in fair value of convertible notes
Amortization of original issue discount and debt issuance costs
Loss on conversions and change in fair value of convertible notes
Loss on issuance of convertible notes
Loss on extinguishment of debt
Issuance costs for convertible notes
Loss on debt conversions
Issuance of liability classified warrants
Change in fair value of liability classified warrants
Issuance of warrants for share subscription facility
Commitment fee for share subscription facility

Warrant modification
Change in fair value of liability classified warrants
Consultant compensation
Stock-based compensation
Issuance of liability classified warrants
Lease cost
Issuance costs for convertible notes
Debt conversion expense
Other income
Depreciation expense
Accrued interest
Changes in operating assets and liabilities
Unbilled receivable
Prepaid expenses and other assets
Accounts payable
Accrued expenses and other liabilities
Net cash used in operating activities
Cash flows from investing activities:
Proceeds from sale of assets
Investment in property and equipment
Net cash flows used in investing activities

Cash flows from financing activities:
Proceeds from public offerings
Proceeds from warrant exercises
Proceeds from warrant inducement, net of issuance costs
Transaction costs from public offerings
Proceeds from issuance of Series B Preferred Stock
Transaction costs associated with public offering and warrant inducements
Proceeds from issuance of convertible notes, net
Proceeds from issuance of promissory notes to related parties
Transaction costs associated with Series B Preferred Stock issuance
Repayment of convertible notes
Repayment of promissory notes
Transaction costs from public offering
Proceeds from exercise of stock options
Proceeds from issuance of common stock for business combination, net of transaction costs
Repayment of financed insurance premiums
Net cash provided by financing activities

Increase in cash and cash equivalents
Cash and cash equivalents beginning of period
Cash and cash equivalents end of period
Supplemental cash flow information:
State minimum tax payments
Supplemental disclosure of non-cash investing and financing activities:
Fair value of derivative liability at issuance
Settlement of convertible notes into common stock
Conversion of 2021 Notes
Financed insurance premiums, net
Stock-based compensation
Incremental fair value of August 2024 Warrant Inducement
Incremental fair value of February 2024 Warrant Inducement
Incremental fair value of April 2025 Warrant Inducement
Transaction costs under accounts payable and accrued expenses
Investment in property and equipment under accounts payable
Conversion of convertible notes into common stock
Payable to related parties settled in shares
Capital contribution from related parties
Net assets acquired in business combination
Original debt discount from convertible notes
Debt discount from warrants issuance
Issuance cost from convertible notes
Financed insurance premiums
Share subscription facility transaction costs
Settlement of commitment fee in shares
Deemed dividend related to warrants down round provision

Comments